New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

Published Date: 12 Jun 2024

Patients with late-stage melanoma may experience a rare but fatal complication called lipomeningeal disease. The leptomeninges, which are membranes covering the brain and spinal cord, are where cancer cells first met and then spread. This condition, .

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot